Related references
Note: Only part of the references are listed.Trial of Early, Goal-Directed Resuscitation for Septic Shock
Paul R. Mouncey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis
Johannes Nemeth et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Extended-Infusion versus Standard-Infusion Piperacillin-Tazobactam for Sepsis Syndromes at a Tertiary Medical Center
Scott R. Cutro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Quantitative data from the SeptiFast real-time PCR is associated with disease severity in patients with sepsis
Ingrid Ziegler et al.
BMC INFECTIOUS DISEASES (2014)
Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes
Nathaniel J. Rhodes et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2014)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program
Ricard Ferrer et al.
CRITICAL CARE MEDICINE (2014)
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
Djamel Mokart et al.
INTENSIVE CARE MEDICINE (2014)
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
J. Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2014)
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Jan J. De Waele et al.
INTENSIVE CARE MEDICINE (2014)
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
Marc Leone et al.
INTENSIVE CARE MEDICINE (2014)
Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia
Younghee Jung et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012
Kirsi-Maija Kaukonen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
F. Tissot et al.
JOURNAL OF INFECTION (2014)
Goal-Directed Resuscitation for Patients with Early Septic Shock
Sandra L. Peake et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Randomized Trial of Protocol-Based Care for Early Septic Shock
Donald M. Yealy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Epidemiology and Outcome of Severe Sepsis and Septic Shock in Intensive Care Units in Mainland China
Jianfang Zhou et al.
PLOS ONE (2014)
An alternate pathophysiologic paradigm of sepsis and septic shock Implications for optimizing antimicrobial therapy
Anand Kumar
VIRULENCE (2014)
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
Stijn Blot et al.
CRITICAL CARE (2014)
Prolonged Infusion Antibiotics for Suspected Gram-Negative Infections in the ICU: A Before-After Study
Heather M. Arnold et al.
ANNALS OF PHARMACOTHERAPY (2013)
Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
Karri A. Bauer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Natasha E. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2013)
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Joel M. Dulhunty et al.
CLINICAL INFECTIOUS DISEASES (2013)
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States
David F. Gaieski et al.
CRITICAL CARE MEDICINE (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Utilization Patterns and Outcomes Associated With Central Venous Catheter in Septic Shock: A Population-Based Study
Allan J. Walkey et al.
CRITICAL CARE MEDICINE (2013)
Aminoglycosides in Septic Shock
Alexandre Boyer et al.
DRUG SAFETY (2013)
Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia
H. R. Palmer et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock
Sheryl Zelenitsky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection
Matthias Willmann et al.
JOURNAL OF INFECTION (2013)
Cytokines and Signaling Molecules Predict Clinical Outcomes in Sepsis
Christopher D. Fjell et al.
PLOS ONE (2013)
Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit
Sai-Ping Jiang et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis
Clarence Chant et al.
CRITICAL CARE (2013)
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study
Jean-Pierre Quenot et al.
CRITICAL CARE (2013)
Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias
P. -Y. Delannoy et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia
J. O. Robinson et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients
Eva Ocampos-Martinez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial
Frank M. Brunkhorst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Frequency of Microbiologically Correct Antibiotic Therapy Increased by Infectious Disease Consultations and Microbiological Results
J. J. Kerremans et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
Ivan Chytra et al.
CRITICAL CARE (2012)
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality
Ana Diaz-Martin et al.
CRITICAL CARE (2012)
Optimization of Aminoglycoside Therapy
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
Marin L. Schweizer et al.
BMC INFECTIOUS DISEASES (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Marta Ulldemolins et al.
CLINICAL PHARMACOKINETICS (2011)
Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock
Julie M. Varghese et al.
CRITICAL CARE CLINICS (2011)
The Relevance of Drug Volume of Distribution in Antibiotic Dosing
Marta Ulldemolins et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials
Ronit Marcus et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) Study: A Multicenter Study
Raymond J. Yost et al.
PHARMACOTHERAPY (2011)
DURATION AND MAGNITUDE OF HYPOTENSION AND MONOCYTE DEACTIVATION IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Peter M. Simon et al.
SHOCK (2011)
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Mi Kyong Joung et al.
CRITICAL CARE (2011)
The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia
Hitoshi Honda et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Effect of Antifungal Therapy Timing on Mortality in Cancer Patients with Candidemia
Ying Taur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
Jared L. Crandon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Mical Paul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Influence of Empiric Therapy with a β-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms
J. A. Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department
David F. Gaieski et al.
CRITICAL CARE MEDICINE (2010)
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock
Mathias W. Pletz et al.
INTENSIVE CARE MEDICINE (2010)
A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients
Donald I. Hsu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Support for higher ciprofloxacin AUC24/MIC targets in treating Enterobacteriaceae bloodstream infection
Sheryl A. Zelenitsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Effectiveness of Treatments for Severe Sepsis A Prospective, Multicenter, Observational Study
Ricard Ferrer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock
Gourang P. Patel et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis
Christian Torgersen et al.
ANESTHESIA AND ANALGESIA (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
Anand Kumar et al.
CHEST (2009)
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study
C. -H. Liao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections
Ayse Erbay et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit
Enrico Raineri et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections
Robert MacLaren et al.
CRITICAL CARE MEDICINE (2008)
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
Peggy S. McKinnon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study
Arthur R. H. van Zanten et al.
JOURNAL OF CRITICAL CARE (2008)
Suboptimal Aminoglycoside Dosing in Critically Ill Patients
Rhonda S. Rea et al.
THERAPEUTIC DRUG MONITORING (2008)
Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study
Sanjay Subramanian et al.
INTENSIVE CARE MEDICINE (2008)
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Glenn A. Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
Sung-Han Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Community-acquired septic shock:: early management and outcome in a nationwide study in Finland
M. Varpula et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2007)
Time-to-positivity in patients with Escherichia coli bacteraemia
G. Peralta et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:: Impact of delayed appropriate antibiotic selection
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Understanding the inflammatory in pneumonia and sepsis - Results of the genetic and inflammatory markers of sepsis (GenIMS) study
John A. Kellum et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Antibiotic management of suspected nosocomial ICU-acquired infection: Does prolonged empiric therapy improve outcome?
Mary-Anne W. Aarts et al.
INTENSIVE CARE MEDICINE (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2007)
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients
Andrew F. Shorr et al.
RESPIRATORY MEDICINE (2006)
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
Mohammad Reza Rafati et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
Morin H. Kollef et al.
CHEST (2006)
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection
AR Marra et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia
R Khatib et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock:: Association with serum lactate and inflammatory cytokine levels
A Kumar et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Time to positivity in Staphylococcus aureus bacteremia:: Possible correlation with the source and outcome of infection
R Khatib et al.
CLINICAL INFECTIOUS DISEASES (2005)
Relationship between fluoroquinolone area under the curve:minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
GL Drusano et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections
GA Pankey et al.
CLINICAL INFECTIOUS DISEASES (2004)
Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease
R Ovstebo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
The importance of bactericidal drugs: Future directions in infectious disease
RW Finberg et al.
CLINICAL INFECTIOUS DISEASES (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia
TP Lodise et al.
CLINICAL INFECTIOUS DISEASES (2003)
Community-acquired bloodstream infection in critically ill adult patients:: Impact of shock and inappropriate antibiotic therapy on survival
J Vallés et al.
CHEST (2003)
Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial
T Duke et al.
LANCET (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Necessity of a loading dose when using vancomycin in critically ill patients
JT Wang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
E Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2001)
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
E Gradelski et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit - A proposed solution for indiscriminate antibiotic prescription
N Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
EH Ibrahim et al.
CHEST (2000)
Share Paper
